| Obstetric cholestasis: outcome with active management. | |
| | |
MedLine Citation:
|
PMID: 11750958 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Conservative management of intrahepatic obstetric cholestasis is associated with a high stillbirth rate despite monitoring of fetal well-being with non-stress test and amniotic fluid volume assessment. Most cases of stillbirth are associated with meconium passage. We prospectively evaluated the effect of a management protocol inclusive of surveillance for presence of meconium and induction of labor at 37 weeks. STUDY DESIGN: Between January 1989 and December 1997, all women with obstetric cholestasis underwent transcervical amnioscopy after 36 weeks for assessment of amniotic fluid color, in addition to standard monitoring of fetal well-being (semi-weekly non-stress test and amniotic fluid volume determinations). Amniocentesis for fetal lung maturity and amniotic fluid color assessment was performed before 36 weeks in severe cases. Labor was induced at 37 weeks or earlier in the presence of non-reassuring fetal testing, meconium, or severe maternal symptoms unresponsive to therapy with mature fetal lungs. The obstetric outcome of the group with cholestasis was compared with that of the general obstetric population at our Institution during the study period. The rate of fetal death in the study group was compared with that of series published within the last 20 years, which used expectancy and conventional monitoring of fetal well-being. Statistical analysis utilized Fisher's exact test, Chi-square, and Student's t-test with P value <0.05 or an odds ratio (OR) with 95% confidence interval (CI) not inclusive of the unity considered significant. RESULTS: Obstetric cholestasis was diagnosed in 206/20,815 pregnant women (1%) at a median gestational age of 34 weeks (range 20-40). Delivery was prompted by non-reassuring fetal testing in four cases (2%). Meconium passage was documented in 33 cases (16%), in 11 of which before onset of labor and in 10 before 37 weeks. The rate of meconium passage before 37 weeks (17.9 versus 2.9%, OR=7.3; 95% CI 3.3, 16.0) was significantly higher in obstetric cholestasis than in the general obstetric population, whereas the cesarean section rate was similar in the two groups (15.1 versus 16.0%, OR=0.9; 95% CI 0.6, 1.4). The fetal death rate was significantly lower in the group managed with the current strategy than in the published series of obstetric cholestasis (0/218 versus 14/888, P=0.045). CONCLUSION: In pregnancies complicated by obstetric cholestasis, a protocol inclusive of search for meconium and elective delivery at 37 weeks, in addition to standard monitoring of fetal well-being, can significantly reduce the stillbirth rate without increasing the cesarean delivery rate. |
| | |
Authors:
|
Nadia Roncaglia; Alessandra Arreghini; Anna Locatelli; Primula Bellini; Camilla Andreotti; Alessandro Ghidini |
Related Documents
:
|
1250558 - Prenatal sex determination by observation of the x-chromatin and the y-chromatin of exf... 9612418 - Electrical potential difference between exocelomic fluid and maternal blood in early pr... 9699758 - Normal amniotic fluid index by gestational week in a chinese population. central-south ... 3803268 - N-acetyl-beta-d-glucosaminidase (nag) levels in amniotic fluid or urine in prenatal and... 15225188 - Urinary nitric oxide metabolite changes in spontaneous and induced onset active labor. 22783998 - Specific role of maternal weight change in the first trimester of pregnancy on birth size. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 100 ISSN: 0301-2115 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 2002 Jan |
Date Detail:
|
Created Date: 2001-12-25 Completed Date: 2002-03-26 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: Ireland |
Other Details:
|
Languages: eng Pagination: 167-70 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Divisione di Ostetricia e Ginecologia, Ospedale San Gerardo, I.S.B.M. San Gerado, University of Milano-Bicocca, Via Solferino 16, 20052, Monza, Italy. pvergan@tin.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Alanine Transaminase / blood Amniotic Fluid Aspartate Aminotransferases / blood Bile Acids and Salts / blood Bilirubin / blood Cholagogues and Choleretics / therapeutic use Cholestasis, Intrahepatic / complications, diagnosis, drug therapy* Cholestyramine Resin / therapeutic use Female Fetal Death / etiology Fetal Monitoring Fetoscopy Gestational Age Humans Labor, Induced Meconium Middle Aged Odds Ratio Pregnancy Pregnancy Complications / drug therapy* S-Adenosylmethionine / therapeutic use Ursodeoxycholic Acid / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Bile Acids and Salts; 0/Cholagogues and Choleretics; 11041-12-6/Cholestyramine Resin; 128-13-2/Ursodeoxycholic Acid; 29908-03-0/S-Adenosylmethionine; 635-65-4/Bilirubin; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.6.1.2/Alanine Transaminase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Risk factors at caesarean section and failure of subsequent trial of labour.
Next Document: The perinatal outcome of pregnancy without prenatal care. A retrospective study in Szeged, Hungary.